Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
about
Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions.MRI detects myocardial iron in the human heart.Magnetic resonance imaging measurement of iron overload.Pathophysiology and Clinical Manifestations of the β-Thalassemias.New developments and controversies in iron metabolism and iron chelation therapy.Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.Renal aspects of thalassaemia a changing paradigm.Impact of educational programme regarding chelation therapy on the quality of life for B-thalassemia major children.Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits.Commentary: Science scandal or ethics scandal? Olivieri redux.
P2860
Q31037298-585AA962-99B0-4A85-9BBD-A45A3F6A83FAQ33921092-8BA61F2B-122F-436C-BAA1-F046CB92CFDCQ33944366-B0560F6D-04F1-44C8-9DE3-195E591E9D43Q36526536-DF6F455C-ED35-4725-9D56-2E01A9C18486Q36719376-FB8D7AF0-A15D-4C31-8CE4-E4EBEB302499Q37376532-0C6423CE-B2B9-4E26-B4DE-C8CE2D07D1DCQ38017754-58B53CD8-C34F-4464-B2E8-23CEC32D1164Q38858532-0AAA9238-D225-49A2-B618-05700C6432F9Q46832149-5FBB3CC9-4FFE-470E-AB67-FD859355E5B4Q48550171-A21DBED9-1595-4531-994B-EA101CB53CFB
P2860
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@en
type
label
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@en
prefLabel
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@en
P2093
P1433
P1476
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@en
P2093
D G Nathan
D J Weatherall
G M Brittenham
M J Pippard
N F Olivieri
P304
183; author reply 183-4
P356
10.1016/S0140-6736(03)12223-4
P407
P577
2003-01-01T00:00:00Z